- Home
- CELC vs CAL Comparison
CELC vs CAL Comparison
Compare CELC & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- CAL
- Stock Information
- Founded
- CELC 2011
- CAL 1878
- Country
- CELC United States
- CAL United States
- Employees
- CELC N/A
- CAL N/A
- Industry
- CELC Medical Specialities
- CAL Shoe Manufacturing
- Sector
- CELC Health Care
- CAL Consumer Discretionary
- Exchange
- CELC Nasdaq
- CAL Nasdaq
- Market Cap
- CELC 440.0M
- CAL 446.5M
- IPO Year
- CELC 2017
- CAL N/A
- Fundamental
- Price
- CELC $57.43
- CAL $15.75
- Analyst Decision
- CELC Strong Buy
- CAL Hold
- Analyst Count
- CELC 5
- CAL 1
- Target Price
- CELC $53.60
- CAL $14.00
- AVG Volume (30 Days)
- CELC 906.9K
- CAL 844.1K
- Earning Date
- CELC 08-14-2025
- CAL 09-04-2025
- Dividend Yield
- CELC N/A
- CAL 1.80%
- EPS Growth
- CELC N/A
- CAL N/A
- EPS
- CELC N/A
- CAL 1.76
- Revenue
- CELC N/A
- CAL $2,652,908,000.00
- Revenue This Year
- CELC N/A
- CAL N/A
- Revenue Next Year
- CELC N/A
- CAL $2.11
- P/E Ratio
- CELC N/A
- CAL $8.84
- Revenue Growth
- CELC N/A
- CAL N/A
- 52 Week Low
- CELC $7.58
- CAL $12.09
- 52 Week High
- CELC $63.06
- CAL $37.70
- Technical
- Relative Strength Index (RSI)
- CELC 64.38
- CAL 58.21
- Support Level
- CELC $50.44
- CAL $15.10
- Resistance Level
- CELC $63.06
- CAL $15.89
- Average True Range (ATR)
- CELC 3.17
- CAL 0.73
- MACD
- CELC -0.47
- CAL 0.04
- Stochastic Oscillator
- CELC 60.71
- CAL 88.70
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.